# Naproxen Sodium Diphenhydramine HCL

NDC: 79903-204
Generic name: Naproxen Sodium Diphenhydramine HCL
Labeler / Manufacturer: Walmart
Product type: HUMAN OTC DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20231214

FDA application: ANDA213663

## Active ingredients

- DIPHENHYDRAMINE HYDROCHLORIDE: 25 mg/1
- NAPROXEN SODIUM: 220 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"79903-204"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=79903-204
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fe810c0e-ab42-5a8a-e053-6394a90affe4